1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (right to buy)
|
Â
(1)
|
02/16/2009 |
Common Stock
|
20,000
|
$
6
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(1)
|
11/15/2009 |
Common Stock
|
7,500
|
$
6
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(1)
|
06/30/2010 |
Common Stock
|
25,000
|
$
8
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(1)
|
11/07/2010 |
Common Stock
|
12,000
|
$
8
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(2)
|
12/18/2016 |
Common Stock
|
14,500
|
$
5.71
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(3)
|
04/17/2017 |
Common Stock
|
39,000
|
$
5.71
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(4)
|
08/06/2017 |
Common Stock
|
35,000
|
$
5.11
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(5)
|
12/11/2017 |
Common Stock
|
50,000
|
$
7.86
|
D
|
Â
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
Fully exercisable. |
(2) |
Exercisable: 4,833 on 12/19/07 and 12/19/08 and 4,834 on 12/19/09. |
(3) |
Exercisable in three equal installments of 13,000 on 4/18/08, 4/18/09 and 4/18/10. |
(4) |
Exercisable: 11,667 on 8/7/08 and 8/7/09 and 11,666 on 8/7/10. |
(5) |
Exercisable: 25,000 on the first anniversary of the closing of the Company's merger with Replidyne, Inc. and 25,000 on the second anniversary of the merger. |